ATE252575T1 - Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung - Google Patents

Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung

Info

Publication number
ATE252575T1
ATE252575T1 AT98936270T AT98936270T ATE252575T1 AT E252575 T1 ATE252575 T1 AT E252575T1 AT 98936270 T AT98936270 T AT 98936270T AT 98936270 T AT98936270 T AT 98936270T AT E252575 T1 ATE252575 T1 AT E252575T1
Authority
AT
Austria
Prior art keywords
indoles
production
dihydroindole derivatives
dihydroindole
derivatives
Prior art date
Application number
AT98936270T
Other languages
English (en)
Inventor
Ejner Knud Moltzen
Jens Kristian Perregaard
Ivan Mikkelsen
Garrick Paul Smith
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE252575T1 publication Critical patent/ATE252575T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT98936270T 1997-07-25 1998-07-20 Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung ATE252575T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5371397P 1997-07-25 1997-07-25
DK89297 1997-07-25
PCT/DK1998/000336 WO1999005140A1 (en) 1997-07-25 1998-07-20 Indole and 2,3-dihydroindole derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE252575T1 true ATE252575T1 (de) 2003-11-15

Family

ID=26064857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936270T ATE252575T1 (de) 1997-07-25 1998-07-20 Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung

Country Status (15)

Country Link
US (2) US6476035B1 (de)
EP (1) EP1007523B9 (de)
JP (1) JP2003524571A (de)
KR (1) KR100545329B1 (de)
AT (1) ATE252575T1 (de)
AU (1) AU736596B2 (de)
BG (1) BG64904B1 (de)
CA (1) CA2297825C (de)
CZ (1) CZ295937B6 (de)
DE (1) DE69819173T2 (de)
ES (1) ES2206963T3 (de)
HU (1) HU225101B1 (de)
NZ (1) NZ502252A (de)
PT (1) PT1007523E (de)
WO (1) WO1999005140A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
WO2000000198A1 (en) 1998-06-30 2000-01-06 Eli Lilly And Company Piperidine derivatives having effects on serotonin related systems
EP1146045A1 (de) * 1998-06-30 2001-10-17 Eli Lilly And Company Auf Serotonin-verwandte Systeme wirkende Piperidin-Derivate
ES2244469T3 (es) * 1999-08-23 2005-12-16 Solvay Pharmaceuticals B.V. Fenilpiperazinas como inhibidores de la recaptacion de serotonina.
WO2001023381A1 (en) * 1999-09-29 2001-04-05 Eli Lilly And Company Piperidine derivatives as reuptake inhibitors
AU7329700A (en) * 1999-09-29 2001-04-30 Eli Lilly And Company Piperidine derivatives as serotonine reuptake inhibitors
WO2002048105A2 (en) * 2000-11-16 2002-06-20 Wyeth Aryloxy piperidinyl derivatives for the treatment of depression
JP4280067B2 (ja) 2001-01-16 2009-06-17 アストラゼネカ・アクチエボラーグ 治療用ヘテロ環式化合物
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US6656950B2 (en) 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
EP1411052B1 (de) 2001-07-05 2011-10-05 Takeda Pharmaceutical Company Limited Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung
AU2002322539B2 (en) 2001-07-20 2007-09-27 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
CA2485136C (en) * 2002-05-13 2011-12-20 F. Hoffmann-La Roche Ag Benzoxazine derivatives as 5-ht6 modulators and uses thereof
DE10326940A1 (de) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indol-Derivate
DE10326939A1 (de) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indol-Derivate
CN101072563A (zh) * 2004-12-07 2007-11-14 索尔瓦药物有限公司 同时对多巴胺-d2受体和5-羟色胺重摄取部位具有亲合力的苯并二噁烷哌嗪衍生物
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US20060122247A1 (en) 2004-12-08 2006-06-08 Solvay Pharmaceuticals B.V. Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
DE102004063797A1 (de) * 2004-12-30 2006-07-13 Schwarz Pharma Ag Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
EP1910573B1 (de) * 2005-07-22 2013-09-04 CytoDyn, Inc. Verfahren zur reduzierung der viruslast in mit hiv-1 infizierten patienten
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
CL2008000119A1 (es) * 2007-01-16 2008-05-16 Wyeth Corp Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
SG173757A1 (en) 2009-03-10 2011-09-29 Takeda Pharmaceutical Benzofuran derivatives
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
RU2013131161A (ru) 2010-12-20 2015-01-27 Астразенека Аб Производное 2-карбоксамид-4-пиперазинил-бензофурана
PL395469A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego
WO2014123766A1 (en) * 2013-02-05 2014-08-14 3M Innovative Properties Company Graphic article
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
CA3248179A1 (en) * 2022-04-19 2023-10-26 Mindset Pharma Inc. Indoline derivatives used as serotonergic agents useful for the treatment of disorders associated with them

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412097A (en) * 1964-09-07 1968-11-19 Koninklijke Pharma Fab Nv Indole derivatives
US5200948A (en) * 1988-02-05 1993-04-06 Tandy Corporation Recording method and apparatus
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
DE4127849A1 (de) 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
CA2275299C (en) * 1996-12-20 2003-12-16 H. Lundbeck A/S Indane or dihydroindole derivatives
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion

Also Published As

Publication number Publication date
US6727263B2 (en) 2004-04-27
EP1007523B9 (de) 2004-09-08
NZ502252A (en) 2001-09-28
US20030018050A1 (en) 2003-01-23
US6476035B1 (en) 2002-11-05
BG64904B1 (bg) 2006-08-31
JP2003524571A (ja) 2003-08-19
BG104148A (en) 2001-05-31
EP1007523B1 (de) 2003-10-22
AU736596B2 (en) 2001-08-02
CA2297825C (en) 2006-03-14
HUP0002830A3 (en) 2001-10-29
HUP0002830A2 (hu) 2001-09-28
DE69819173D1 (de) 2003-11-27
WO1999005140A1 (en) 1999-02-04
CA2297825A1 (en) 1999-02-04
EP1007523A1 (de) 2000-06-14
AU8534098A (en) 1999-02-16
KR20010022229A (ko) 2001-03-15
DE69819173T2 (de) 2004-04-15
ES2206963T3 (es) 2004-05-16
PT1007523E (pt) 2004-02-27
KR100545329B1 (ko) 2006-01-24
CZ295937B6 (cs) 2005-12-14
CZ2000285A3 (cs) 2000-06-14
HU225101B1 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
ATE252575T1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
DE60004066D1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
TR200101744T2 (tr) Fenilglisin türevleri.
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DE69718194D1 (de) Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate
SE9702773D0 (sv) Novel compounds
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
ATE277010T1 (de) Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
YU78100A (sh) 4,5,6 i 7-indol i indolin derivati, njihova izrada i upotreba
DE69707672D1 (de) Dibenzo-oxazepin- und dioxepin-derivate und ihre verwendung als antitumormittel
DE59901563D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
EA200000162A1 (ru) Производные индола и 2,3-дигидроиндола, их получение и использование
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ATE264320T1 (de) 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole
NO20010513L (no) Nye 2,3,3a,4,9,9a heksahydro-8-hydroksy-1H-benz[f]indoler, en fremgangsmÕte for fremstilling derav og deres anvendelse som medikamenter
MX9706872A (es) Derivados de piperazinona sustituidos por heterociclico como antagonistas de receptor de taquiquinina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007523

Country of ref document: EP

REN Ceased due to non-payment of the annual fee